{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for valproic root_modifications_structuralModifications_molecularFragment_refPname in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:cofetuzumab pelidotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT00003478: Phase 1/Phase 2 Interventional Completed Brain and Central Nervous System Tumors
(1997)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pegapamodutide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT01222286: Phase 2 Interventional Completed Smoldering Multiple Myeloma
(2010)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:emactuzumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sotigalimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:marzeptacog alfa (activated) [INN]
Source URL:
Class:
PROTEIN